Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims

Objectives To estimate the frequency and characteristics of opioid prescribing by multiple providers in Medicare and the association with hospital admissions related to opioid use. Design Retrospective cohort study. Setting Database of prescription drugs and medical claims in 20% random sample of Medicare beneficiaries in 2010. Participants 1 808 355 Medicare beneficiaries who filled at least one prescription for an opioid from a pharmacy in 2010. Main outcome measures Proportion of beneficiaries who filled opioid prescriptions from multiple providers; proportion of these prescriptions that were concurrently supplied; adjusted rates of hospital admissions related to opioid use associated with multiple provider prescribing. Results Among 1 208 100 beneficiaries with an opioid prescription, 418 530 (34.6%) filled prescriptions from two providers, 171 420 (14.2%) from three providers, and 143 344 (11.9%) from four or more providers. Among beneficiaries with four or more opioid providers, 110 671 (77.2%) received concurrent opioid prescriptions from multiple providers, and the dominant provider prescribed less than half of the mean total prescriptions per beneficiary (7.9/15.2 prescriptions). Multiple provider prescribing was highest among beneficiaries who were also prescribed stimulants, non-narcotic analgesics, and central nervous system, neuromuscular, and antineoplastic drugs. Hospital admissions related to opioid use increased with multiple provider prescribing: the annual unadjusted rate of admission was 1.63% (95% confidence interval 1.58 to 1.67%) for beneficiaries with one provider, 2.08% (2.03% to 2.14%) for two providers, 2.87% (2.77% to 2.97%) for three providers, and 4.83% (4.70% to 4.96%) for four or more providers. Results were similar after covariate adjustment. Conclusions Concurrent opioid prescribing by multiple providers is common in Medicare patients and is associated with higher rates of hospital admission related to opioid use.

[1]  P. Christo,et al.  The influence of prescription monitoring programs on chronic pain management. , 2009, Pain physician.

[2]  Daniel M. Hartung,et al.  Rates of Adverse Events of Long-Acting Opioids in a State Medicaid Program , 2007, The Annals of pharmacotherapy.

[3]  Hassan Baxi,et al.  Time series analysis of California's prescription monitoring program: impact on prescribing and multiple provider episodes. , 2012, The journal of pain : official journal of the American Pain Society.

[4]  R. Cohen,et al.  Medicare Advantage Chronic Special Needs Plan boosted primary care, reduced hospital use among diabetes patients. , 2012, Health affairs.

[5]  K. Saunders,et al.  Relationship of Opioid Use and Dosage Levels to Fractures in Older Chronic Pain Patients , 2010 .

[6]  Lesley H Curtis,et al.  Inappropriate prescribing for elderly Americans in a large outpatient population. , 2004, Archives of internal medicine.

[7]  Michael J Smith,et al.  Doctor and Pharmacy Shopping for Controlled Substances , 2012, Medical care.

[8]  W. Ling,et al.  Prescription opioid abuse, pain and addiction: clinical issues and implications. , 2011, Drug and alcohol review.

[9]  Bradley C. Martin,et al.  Trends in use of opioids for non-cancer pain conditions 2000–2005 in Commercial and Medicaid insurance plans: The TROUP study , 2008, PAIN.

[10]  Wing Chow,et al.  A Large Cohort Study from a Medication Dispensing Database in the US , 2012 .

[11]  L. Leresche,et al.  Age and gender trends in long-term opioid analgesic use for noncancer pain. , 2010, American journal of public health.

[12]  A. Spinewine,et al.  2012 Updated Beers Criteria: Greater Applicability to Europe? , 2012, Journal of the American Geriatrics Society.

[13]  Lisa M. Schwartz,et al.  Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000 , 2004, Pain.

[14]  S. Fishman,et al.  Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics. , 2010, Drug and alcohol dependence.

[15]  D. Juurlink,et al.  Facing up to the prescription opioid crisis , 2011, British medical journal.

[16]  Sangho Moon,et al.  Health care utilization among Medicare-Medicaid dual eligibles: a count data analysis , 2006, BMC public health.

[17]  S. Davis,et al.  Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. , 2010, American Journal of Preventive Medicine.

[18]  S. Fishman,et al.  An analysis of the number of multiple prescribers for opioids utilizing data from the California Prescription Monitoring Program , 2011, Pharmacoepidemiology and drug safety.

[19]  Susan Okie,et al.  A flood of opioids, a rising tide of deaths. , 2010, The New England journal of medicine.

[20]  Ray Wang,et al.  Hospital readmission rates in Medicare Advantage plans. , 2012, The American journal of managed care.

[21]  N. Brennan,et al.  Comparing quality of care in the Medicare program. , 2010, The American journal of managed care.

[22]  Yongli Xi,et al.  Increasing deaths from opioid analgesics in the United States , 2006, Pharmacoepidemiology and drug safety.

[23]  P. Gallagher,et al.  Inappropriate prescribing and adverse drug events in older people , 2009, BMC geriatrics.

[24]  J. Berlin,et al.  Characteristics of prescribers whose patients shop for opioids: results from a cohort study. , 2012, Journal of opioid management.

[25]  Emily R. Hajjar,et al.  Unnecessary Drug Use in Frail Older People at Hospital Discharge , 2005, Journal of the American Geriatrics Society.

[26]  D. Webster,et al.  Rethinking opioid prescribing to protect patient safety and public health. , 2012, JAMA.

[27]  Leonard J Paulozzi,et al.  Prescription drug monitoring programs and death rates from drug overdose. , 2011, Pain medicine.

[28]  Jonathan N. Hawley,et al.  Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? , 2007, The American journal of geriatric pharmacotherapy.

[29]  Meelee Kim,et al.  Usefulness of prescription monitoring programs for surveillance—analysis of Schedule II opioid prescription data in Massachusetts, 1996–2006 , 2010, Pharmacoepidemiology and drug safety.

[30]  O. Blin,et al.  Impact of a prescription monitoring program on doctor‐shopping for high dosage buprenorphine , 2009, Pharmacoepidemiology and drug safety.

[31]  S. Soumerai,et al.  Racial disparities in access after regulatory surveillance of benzodiazepines. , 2006, Archives of internal medicine.

[32]  B. Psaty,et al.  Opioid Prescriptions for Chronic Pain and Overdose , 2010, Annals of Internal Medicine.

[33]  M Soledad Cepeda,et al.  Assessing Opioid Shopping Behaviour , 2012, Drug Safety.

[34]  J. Rassen,et al.  The comparative safety of analgesics in older adults with arthritis. , 2010, Archives of internal medicine.

[35]  G. Pasternak,et al.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. , 2009, The journal of pain : official journal of the American Pain Society.

[36]  Cathy Schoen,et al.  Physician–Patient Communication About Prescription Medication Nonadherence: A 50-state Study of America’s Seniors , 2007, Journal of General Internal Medicine.

[37]  T. Stürmer,et al.  Opioid Analgesics and the Risk of Fractures in Older Adults with Arthritis , 2011, Journal of the American Geriatrics Society.

[38]  B. Friedman,et al.  Managed care and preventable hospitalization among Medicaid adults. , 2004, Health services research.

[39]  J David Haddox,et al.  Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data. , 2004, The American journal of managed care.

[40]  L. Paulozzi,et al.  Opioid analgesics and rates of fatal drug poisoning in the United States. , 2006, American journal of preventive medicine.

[41]  Florence T. Bourgeois,et al.  Adverse drug events in the outpatient setting: an 11‐year national analysis , 2010, Pharmacoepidemiology and drug safety.

[42]  J. Cooper,et al.  Polypharmacy in the aged. Practical solutions. , 1994, Drugs & aging.

[43]  Leonard J. Paulozzi,et al.  Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. , 2011, MMWR. Morbidity and mortality weekly report.